TAZOLOL

Investigational

Details

Stereochemistry	RACEMIC
Molecular Formula	C9H16N2O2S
Molecular Weight	216.301
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

CC(C)NCC(O)COC1=NC=CS1

InChI

InChIKey=DREVJBVJBRSSDL-UHFFFAOYSA-N

InChI=1S/C9H16N2O2S/c1-7(2)11-5-8(12)6-13-9-10-3-4-14-9/h3-4,7-8,11-12H,5-6H2,1-2H3

HIDE SMILES / InChI

Description

Tazolol is a selective myocardial beta-blocking agent. Experiments on dogs have shown that this compound could be useful in patients with heart failure due to coronary artery disease. However, information about the current use of tazolol is not available.

Approval Year

Targets

Targets

Primary Target	Pharmacology	Condition	Potency
Adrenergic receptor beta 87	Agonist 2,678

PubMed

Title	Date	PubMed
No data available in table

Patents

Show entries

Name

Type

Language

TAZOLOL

Official Name

English

(±)-1-(ISOPROPYLAMINO)-3-(2-THIAZOLYLOXY)-2-PROPANOL

Systematic Name

English

tazolol [INN]

Common Name

English

2-PROPANOL, 1-((1-METHYLETHYL)AMINO)-3-(2-THIAZOLYLOXY)-, (±)-

Systematic Name

English

Showing 1 to 4 of 4 entries

Previous1Next

Show entries

Classification Tree

Code System

Code

Adrenergic Antagonist

NCI_THESAURUS

C29576

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Code System

Code

Type

Description

SMS_ID

100000082434

PRIMARY

PUBCHEM

71721

PRIMARY

ChEMBL

CHEMBL2111158

PRIMARY

WIKIPEDIA

TAZOLOL

PRIMARY

EPA CompTox

DTXSID80865972

PRIMARY

Showing 1 to 5 of 11 entries

Previous1 2 3Next

ACTIVE MOIETY


					B64Q38TX4G

TAZOLOL

SALT/SOLVATE (PARENT)


					17VCV89R3L

TAZOLOL HYDROCHLORIDE